Drugplain

Quillivant XR 300 mg/60mL

methylphenidate hydrochloride · SUSPENSION, EXTENDED RELEASE · NextWave Pharmaceuticals, Inc

No Recall HistoryCurrently in Shortage
Plain English

Quillivant XR is a liquid suspension of methylphenidate, a stimulant medication used to treat attention-deficit/hyperactivity disorder (ADHD) in children. It is designed to release the medication gradually throughout the day to provide long-lasting symptom control.

Key Facts

Brand Name
Quillivant XR
Generic Name
methylphenidate hydrochloride
NDC Code (Product)
24478-321
Manufacturer
NextWave Pharmaceuticals, Inc
Strength
300 mg/60mL
Dosage Form
SUSPENSION, EXTENDED RELEASE
Route
ORAL
Marketing Status
DEA Schedule
Schedule II (Controlled)
Application #
NDA202100
Marketing Start
10/01/2012

Recall History

No Recall History

Frequently Asked Questions

What is Quillivant XR used for?

Quillivant XR is a liquid suspension of methylphenidate, a stimulant medication used to treat attention-deficit/hyperactivity disorder (ADHD) in children. It is designed to release the medication gradually throughout the day to provide long-lasting symptom control.

Is Quillivant XR a controlled substance?

Yes, Quillivant XR is classified as CII under the DEA Controlled Substances Act.

What is the generic name for Quillivant XR?

The generic name for Quillivant XR is methylphenidate hydrochloride. There are 12 other brand versions of methylphenidate hydrochloride.

What is the NDC code for Quillivant XR 300 mg/60mL?

The NDC (National Drug Code) for Quillivant XR 300 mg/60mL is 24478-321, listed by NextWave Pharmaceuticals, Inc.

Product NDC

24478-321

Package NDC

24478-321-02

Other Methylphenidate Brands

See all →

Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.

Data from openFDA · Public domain (CC0 1.0)